SCHEMBL26503877

SCHEMBL26503877

CCC(Oc1ccc2c(-c3ccccc3Cl)cc(=O)oc2c1)C(=O)N1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ AR P10275 1/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 5/20 0.44
▸ HPGD P15428 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ HTT P42858 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ USP2 O75604 1/20 0.41
▸ IGLV6-57 P01721 1/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30360913 1.00 CA12 (0.48) CA12CA9ARKMT2AMEN1
SCHEMBL30055555 0.90 RAB9A (0.46) CA12CA9ARKMT2AMEN1
SCHEMBL20839050 0.90 RAB9A (0.46) CA12CA9ARKMT2AMEN1
SCHEMBL30055832 0.88 ALDH1A1 (0.51) ARKMT2AMEN1ALDH1A1HPGD
SCHEMBL20848101 0.88 ALDH1A1 (0.51) ARKMT2AMEN1ALDH1A1HPGD
SCHEMBL20839063 0.88 ALDH1A1 (0.56) CA12CA9ARKMT2AMEN1
SCHEMBL20839060 0.88 ALDH1A1 (0.56) CA12CA9ARKMT2AMEN1
SCHEMBL30058125 0.87 ALDH1A1 (0.57) CA12CA9ARKMT2AMEN1
SCHEMBL20839376 0.87 ALDH1A1 (0.57) CA12CA9ARKMT2AMEN1
SCHEMBL30360854 0.86 RAB9A (0.47) CA12CA9ARKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3684762-B1 COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER LEAD DISCOVERY CENTER GMBH (DE) 2023-05-03 — — EP disclosed
Send feedback